Atopic Dermatitis at Fall Clinical: What Stayed With You?

Patients who began with severe atopic dermatitis often arrive at follow-up genuinely relieved, and that relief can make them hesitant to mention what still isn’t right. Speaking after Fall Clinical 2026, Mona Shahriari, MD, considers how to make room for that conversation. She starts with long-term observational data from RELIEVE-AD on how patients treated with dupilumab described the effect of AD on their sleep and daily lives. She then describes the questions she now asks once a patient is doing better, and why one of them is about happiness rather than symptoms. Her closing pearl separates improvement from control, and control from something patients may want more.